Sustained Clinical Quiescence in Anti-Scl-70 Positive Systemic Sclerosis During Long-Term Entecavir Therapy: A Potential Role for NLRP3 Inflammasome Inhibition?

Graphical AbstractDisplay full size

Authors

Institutions

Publication Details

Journal
Immunopharmacology and Immunotoxicology
Published
2026-08-27
DOI
https://doi.org/10.1080/08923973.2026.2725840
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Sustained Clinical Quiescence in Anti-Scl-70 Positive Systemic Sclerosis During Long-Term Entecavir Therapy: A Potential Role for NLRP3 Inflammasome Inhibition?

Angelo Nigro
Immunopharmacology and Immunotoxicology
Respiratory viral infections research
article

Sustained Clinical Quiescence in Anti-Scl-70 Positive Systemic Sclerosis During Long-Term Entecavir Therapy: A Potential Role for NLRP3 Inflammasome Inhibition?

Angelo Nigro
article en

Abstract

No abstract available for this paper.

Immunopharmacology and Immunotoxicology
Ospedale Madonna Delle Grazie (IT)
Openalex Percentile: Top 10%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.